.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Dow
Healthtrust
Federal Trade Commission
Citi
QuintilesIMS
US Army
Accenture
Argus Health

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,900,488

« Back to Dashboard

Which drugs does patent 5,900,488 protect, and when does it expire?


Patent 5,900,488 protects LUZU and is included in one NDA.

This patent has thirty-three patent family members in twenty-four countries.

Summary for Patent: 5,900,488

Title: Method for treating mycosis using imidazolylacetonitrile derivatives
Abstract:R-(+)-(E)-[4-(2-Chlorophenyl)-1,3-dithiolan-2-ylidene]-1-imidazolylacetonit rile, R-(-)-(E)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1-imidazolylace tonitrile, and pharmaceutically acceptable salts thereof which can be used as a pharmaceutical agent are disclosed. A process for producing them and a method for treating mycoses using them are also disclosed.
Inventor(s): Kodama; Hiroki (Osaka, JP), Niwano; Yoshimi (Osaka, JP), Kanai; Kazuo (Osaka, JP), Yoshida; Masanori (Wakayama, JP)
Assignee: Nihon Nohyaku Co., Ltd. (Tokyo, JP)
Application Number:08/981,420
Patent Claim Types:
see list of patent claims
Compound; Composition; Process; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes5,900,488► SubscribeYY TREATMENT OF FUNGAL INFECTIONS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,900,488

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan7-196174Jul 8, 1995
PCT Information
PCT FiledJuly 05, 1996PCT Application Number:PCT/JP96/01872
PCT Publication Date:January 30, 1997PCT Publication Number: WO97/02821

International Patent Family for Patent: 5,900,488

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2226214► Subscribe
Switzerland692045► Subscribe
China1194582► Subscribe
China1091596► Subscribe
Germany19681478► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
AstraZeneca
McKesson
Citi
Julphar
Covington
Harvard Business School
Deloitte
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot